325 related articles for article (PubMed ID: 31136822)
1. Low Responsiveness of Basophils via FcεRI Reflects Disease Activity in Chronic Spontaneous Urticaria.
Oda Y; Fukunaga A; Washio K; Imamura S; Hatakeyama M; Ogura K; Nishigori C
J Allergy Clin Immunol Pract; 2019; 7(8):2835-2844.e7. PubMed ID: 31136822
[TBL] [Abstract][Full Text] [Related]
2. Improved FcεRI-Mediated CD203c Basophil Responsiveness Reflects Rapid Responses to Omalizumab in Chronic Spontaneous Urticaria.
Oda Y; Fukunaga A; Washio K; Imamura S; Mizuno M; Hatakeyama M; Ogura K; Nishigori C
J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1166-1176.e8. PubMed ID: 32898709
[TBL] [Abstract][Full Text] [Related]
3. Activated steady status and distinctive FcεRI-mediated responsiveness in basophils of atopic dermatitis.
Imamura S; Washio K; Mizuno M; Oda Y; Fukunaga A; Nishigori C
Allergol Int; 2021 Jul; 70(3):327-334. PubMed ID: 33674191
[TBL] [Abstract][Full Text] [Related]
4. Relevance of the Basophil High-Affinity IgE Receptor in Chronic Urticaria: Clinical Experience from a Tertiary Care Institution.
Deza G; March-Rodríguez A; Sánchez S; Ribas-Llauradó C; Soto D; Pujol RM; Gimeno R; Giménez-Arnau AM
J Allergy Clin Immunol Pract; 2019; 7(5):1619-1626.e1. PubMed ID: 30685572
[TBL] [Abstract][Full Text] [Related]
5. Response of FcεRI-bearing leucocytes to omalizumab in chronic spontaneous urticaria.
Alizadeh Aghdam M; Knol EF; van den Elzen M; den Hartog Jager C; van Os-Medendorp H; Knulst AC; Otten HG; Röckmann H
Clin Exp Allergy; 2020 Mar; 50(3):364-371. PubMed ID: 31925825
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of omalizumab treatment in chronic spontaneous urticaria is associated with basophil phenotypes.
Johal KJ; Chichester KL; Oliver ET; Devine KC; Bieneman AP; Schroeder JT; MacGlashan DW; Saini SS
J Allergy Clin Immunol; 2021 Jun; 147(6):2271-2280.e8. PubMed ID: 33713769
[TBL] [Abstract][Full Text] [Related]
7. Differentiation between control subjects and patients with chronic spontaneous urticaria based on the ability of anti-IgE autoantibodies (AAbs) to induce FcεRI crosslinking, as compared to anti-FcεRIα AAbs.
Izaki S; Toyoshima S; Endo T; Kanegae K; Nunomura S; Kashiwakura JI; Sasaki-Sakamoto T; Nakamura R; Akiyama H; Ra C; Hayama K; Terui T; Okayama Y
Allergol Int; 2019 Jul; 68(3):342-351. PubMed ID: 30803853
[TBL] [Abstract][Full Text] [Related]
8. Response of peripheral blood basophils in subjects with chronic spontaneous urticaria during treatment with omalizumab.
MacGlashan D; Saini S; Schroeder JT
J Allergy Clin Immunol; 2021 Jun; 147(6):2295-2304.e12. PubMed ID: 33716077
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers and clinical characteristics of autoimmune chronic spontaneous urticaria: Results of the PURIST Study.
Schoepke N; Asero R; Ellrich A; Ferrer M; Gimenez-Arnau A; E H Grattan C; Jakob T; Konstantinou GN; Raap U; Skov PS; Staubach P; Kromminga A; Zhang K; Bindslev-Jensen C; Daschner A; Kinaciyan T; Knol EF; Makris M; Marrouche N; Schmid-Grendelmeier P; Sussman G; Toubi E; Church MK; Maurer M
Allergy; 2019 Dec; 74(12):2427-2436. PubMed ID: 31228881
[TBL] [Abstract][Full Text] [Related]
10. IgE receptor responsiveness of basophils in chronic inducible urticaria.
Mizuno M; Oda Y; Imamura S; Washio K; Fukumoto T; Fukunaga A
Front Immunol; 2022; 13():995596. PubMed ID: 36211415
[TBL] [Abstract][Full Text] [Related]
11. Higher House Dust Mite-Specific IgE Levels among Chronic Spontaneous Urticaria Patients May Implicate Higher Basophil Reactivity.
Liang G; Zhou J; Jiang L; Wang W; Wu Q; Gao C; Liu W; Li S; Feng S; Song Z
Int Arch Allergy Immunol; 2023; 184(11):1126-1134. PubMed ID: 37604140
[TBL] [Abstract][Full Text] [Related]
12. Functional and phenotypic analysis of basophils allows determining distinct subtypes in patients with chronic urticaria.
Rauber MM; Pickert J; Holiangu L; Möbs C; Pfützner W
Allergy; 2017 Dec; 72(12):1904-1911. PubMed ID: 28585360
[TBL] [Abstract][Full Text] [Related]
13. The CD63 basophil activation test as a diagnostic tool for assessing autoimmunity in patients with chronic spontaneous urticaria.
HOssein Zadeh Attar M; Merk HF; Kotliar K; Wurpts G; Röseler S; Moll-Slodowy S; Plange J; Baron JM; Balakirski G
Eur J Dermatol; 2019 Dec; 29(6):614-618. PubMed ID: 31903951
[TBL] [Abstract][Full Text] [Related]
14. Clinical efficacy of omalizumab in chronic spontaneous urticaria is associated with a reduction of FcεRI-positive cells in the skin.
Metz M; Staubach P; Bauer A; Brehler R; Gericke J; Kangas M; Ashton-Chess J; Jarvis P; Georgiou P; Canvin J; Hillenbrand R; Erpenbeck VJ; Maurer M
Theranostics; 2017; 7(5):1266-1276. PubMed ID: 28435464
[No Abstract] [Full Text] [Related]
15. An immunoglobulin E-reactive chimeric human immunoglobulin G1 anti-idiotype inhibits basophil degranulation through cross-linking of FcepsilonRI with FcgammaRIIb.
Wigginton SJ; Furtado PB; Armour KL; Clark MR; Robins A; Emara M; Ghaemmaghami AM; Sewell HF; Shakib F
Clin Exp Allergy; 2008 Feb; 38(2):313-9. PubMed ID: 18070161
[TBL] [Abstract][Full Text] [Related]
16. Relationship between changes in the 7-day urticaria activity score after treatment with omalizumab and the responsiveness of basophils to FcεRI stimulation in patients with chronic spontaneous urticaria.
Endo T; Toyoshima S; Hayama K; Tagui M; Niwa Y; Ito M; Terui T; Okayama Y
Asia Pac Allergy; 2020 Apr; 10(2):e12. PubMed ID: 32411577
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies to IgE and FcεRI and the natural variability of spleen tyrosine kinase expression in basophils.
MacGlashan D
J Allergy Clin Immunol; 2019 Mar; 143(3):1100-1107.e11. PubMed ID: 29859965
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers of Autologous Whole Blood Injection Efficacy in Patients with Chronic Spontaneous Urticaria with Autoreactivity: A Preliminary Study.
Chen Q; Luo J; Yang X; Chen W; Liu W; Song Z
Int Arch Allergy Immunol; 2024; 185(2):190-195. PubMed ID: 37952519
[TBL] [Abstract][Full Text] [Related]
19. Double-blind placebo-controlled trial of the effect of omalizumab on basophils in chronic urticaria patients.
Jörg L; Pecaric-Petkovic T; Reichenbach S; Coslovsky M; Stalder O; Pichler W; Hausmann O
Clin Exp Allergy; 2018 Feb; 48(2):196-204. PubMed ID: 29164723
[TBL] [Abstract][Full Text] [Related]
20. What Basophil Testing Tells Us About CSU Patients - Results of the CORSA Study.
Marcelino J; Baumann K; Skov PS; Pereira Santos MC; Wyroslak I; Scheffel J; Altrichter S; Woetmann A; Pereira-Barbosa M; Costa C; Maurer M
Front Immunol; 2021; 12():742470. PubMed ID: 34650565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
